Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology Reports|July 18, 2025
Exceptional response to trastuzumab deruxtecan in recurrent neuroendocrine cervical cancer: A case reportLauren Tostrud, Brooke E Howitt, Margaret Mills, et al.
Cancer Medicine|August 21, 2018
Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry studyMana Baskovic, Daphne Y Lichtensztajn, Trung Nguyen, et al.
Journal of Minimally Invasive Gynecology|April 14, 2019
Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United StatesMalte Renz, Elisabeth Diver, Diana English, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2024
Controversies in the Surgical Management of Gynecologic Cancer: Balancing the Decision to Operate or HesitateSahana Somasegar, Mary Katherine Anastasio, Amer Karam, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 10, 2015
Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the LiteratureLindsay Wheeler, Gina L Westhoff, Mary C O'Keefe, et al.
Gynecologic Oncology|February 8, 2024
Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysisSahana Somasegar, Ravali A Reddy, Stephanie Chow, et al.
Immunotherapy|September 19, 2025
Durable response to an anti-CD25 antibody-drug conjugate and anti-PD-1 antibody in ovarian carcinoma: a case reportFaraah Bekheet, Melanie Ashland, Rochelle Reyes, et al.
Gynecologic Oncology Reports|March 24, 2025
Fertility-sparing treatment for atypical polypoid adenomyomaIsabel Beshar, Susan Lang, Oliver Dorigo, et al.
Gynecologic Oncology|February 19, 2026
Pre-operative cross-sectional imaging of chest, abdomen, pelvis is not cost-effective for low-grade endometrial cancerIsabel Beshar, Arian Khorshid, Sahana Somasegar, et al.
Pageof 4